Clik here to view.
Medtronic touts economic data for HeartWare HVAD
Medtronic (NYSE:MDT) today touted more data on the HeartWare left-ventricular assist device it acquired in 2016, saying economic analyses of prior trials showed its cost effectiveness. The Fridley,...
View ArticleClik here to view.
Medtronic touts stroke data for HeartWare LVAD
A retrospective analysis of two studies involved the HeartWare left-ventricular assist device Medtronic (NYSE:MDT) acquired in 2016 showed that managing blood pressure reduced the severity of strokes...
View ArticleClik here to view.
Report: Drones are delivering blood samples in N.C.
Autonomous drones have begun to ferry blood samples between clinics and labs in the skies over North Carolina, according to a recent report from Wired. The drone service, run by UPS with drone...
View ArticleClik here to view.
Homeland Security details vulnerabilities in Medtronic ICD, CRT-Ds, CareLink...
The U.S. Dept. of Homeland Security today released a medical advisory warning of exploits within a number of Medtronic (NYSE:MDT) implanted cardiac devices and associated equipment that could allow an...
View ArticleClik here to view.
ACC 2019 Roundup – ReCor touts six-month Paradise renal denervation study...
ReCor Medical this week released “on-medication” results from the RADIANCE-HTN-SOLO clinical trial of its Paradise renal denervation system intended to treat uncontrolled hypertension, touting...
View ArticleClik here to view.
ACC 2019 Roundup: Abiomed Impella RP post-market study shows benefit in...
Abiomed (NSDQ:ABMD) today released 18-month post-approval study data from patients treated with its Impella RP, touting a benefit to survival for specifically selected “Recover Right” protocol...
View ArticleClik here to view.
Biotronik wins FDA nod for Acticor, Rivacor high-voltage tachycardia devices
Biotronik said yesterday it won FDA approval for its Acticor and Rivacor high-voltage cardiac rhythm management devices intended for treating patients with cardiac arrhythmias. The clearance covers...
View ArticleClik here to view.
Patient deaths prompt renewed warning to heed LifeVest alert
FDA has issued another update to a previous voluntary recall of Asahi Kasei (TYO:3407) subsidiary Zoll Medical‘s LifeVest 4000 wearable automatic external defibrillators following two patient deaths....
View ArticleClik here to view.
Study finds fault with ICD leads that Abbott inherited from St. Jude Medical
A review of FDA adverse event reports has revealed that some Abbott (NYSE:ABT) implantable cardioverter defibrillator (ICD) leads were much more likely than those made by Boston Scientific or Medtronic...
View ArticleClik here to view.
FDA gives massive Medtronic recall Class I designation
FDA has slapped the most serious designation on a recall of approximately 156,957 Medtronic (NYSE:MDT) dual-chamber pacemakers. The Fridley, Minn.-based company issued a recall in January on...
View ArticleClik here to view.
Leviticus Cardio, Jarvik Heart unveil wireless LVAD
Jarvik Heart and Leviticus Cardio yesterday unveiled a new collaborative wirelessly-powered left ventricular assist device and touted its recent first-in-human use. An article on the new heart and its...
View ArticleClik here to view.
Thoratec inks $12m investor suit settlement deal
Abbott (NYSE:ABT) owned Thoratec is seeking approval for a $11.9 million deal to settle class action claims that it and some of its officers hid facts about its Heartmate II heart pump’s thrombosis...
View ArticleClik here to view.
Vectorious starts trial of implantable wireless heart monitor
Vectorious Medical Technologies said it has begun a first-in-human trial of its left atrial pressure monitoring device. Tel Aviv-based Vectorious is developing the V-Lap implantable wireless heart...
View ArticleClik here to view.
FDA: Interim data from post-market Abiomed Impella RP study shows 17%...
The FDA yesterday said that interim data from a post-approval study of Abiomed‘s (NSDQ:ABMD) Impella RP heart pump system showed only a 17.4% survival rate, approximately 55% lower than the rate noted...
View ArticleClik here to view.
Could this device replace pacemaker batteries?
Rendering of the two designs of Dartmouth University researchers’ cardiac energy-harvesting device. (Art by Patricio Sarzosa.) The heart’s motion is so powerful that it can recharge lifesaving cardiac...
View ArticleClik here to view.
Stryker recalls select Lifepak 15 defibs on lock-up issues
Stryker (NYSE:SYK) said last Friday that it is launching a select voluntary recall of Lifepak 15 monitor/defibrillators over issues in which the device locks up and may not deliver life-saving...
View ArticleClik here to view.
Circuit error prompts Medtronic to recall 157k dual-chamber pacers
Medtronic (NYSE:MDT) is suspending distribution and selectively recalling approximately 156,957 of its Adapta, Versa and Sensia dual-chamber pacers over circuit error issues that could affect overall...
View ArticleClik here to view.
Medtronic launches MyCareLink Heart pacer-connected smartphone app
Medtronic (NYSE:MDT) said today that it launched its MyCareLink Heart mobile application intended to connect users’ smartphone devices directly to the company’s portfolio of connected pacemakers,...
View ArticleClik here to view.
Abiomed wants whistleblower to cough up employment records
Abiomed (NSDQ:ABMD) yesterday asked a federal judge to force whistleblower Max Bennett to cough up his employment records with another company, countering his retaliatory termination claim by alleging...
View ArticleClik here to view.
Ex-Abiomed exec loses $2m lawsuit
A former Abiomed (NSDQ:ABMD) Asia VP lost a lawsuit that sought $2.1 million in damages, alleging unfair termination and the denial of an options deal tied to Japanese approval of its Impella heart...
View Article
![[-100%] Commodity Intelligence – (Android Apps)](http://play-lh.googleusercontent.com/j67-qJvmnn4xnVlYVZ9ZhtZUJIgwjKekJGoKQT6D1KHcWGZxtQaFroummEvwV17na7tyh1pGbbeWCRdWtTKqeg=w950-h950)